Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Business Context and Reporting Period

This Form 8-K Current Report was filed by Ekso Bionics Holdings, Inc. on April 7, 2015. The report details corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new director.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.

Material Changes

  • Board Expansion: The Board of Directors voted to increase the number of directors from six to seven.
  • New Appointment: Amy McBride Wendell was elected to serve as a director.
  • Compensation Arrangement: Ms. Wendell was awarded an option to purchase 200,000 shares of common stock, exercisable over four years. She is also entitled to a $10,000 annual retainer plus $5,000 for each Board Committee served.

Guidance, Outlook, and Risks

The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. It notes that Ms. Wendell is anticipated to enter into the Company's standard indemnification agreement for directors.

Investor Verification Checklist

  • Verify the total number of outstanding shares and the dilution impact of the 200,000 new stock options granted.
  • Confirm the specific committees on which Ms. Wendell will serve to calculate total annual retainer obligations.
  • Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for the board expansion.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.